BoTower Capital scouts and supports the growth through discovery, pre-seed or seed phase of the most promising projects with innovative potential in the fields of MedTech, Diagnostics and Drug Discovery from the Central & East Europe region and Middle East region.
Benefitting from the know-how and networking skills of Micar Innovation and Exact Sciences Foundation, we can provide the expertise and contacts to help our chosen projects grow into an established business. We can also provide financial support and investment to accelerate the proof-of-concept stage of projects in life science.
Our ambition is to become a leading partner and support agency advancing and promoting game-changing biotech inventions coming from the Central & East Europe region and Middle East region.
Great ideas and significant innovations can originate anywhere! However, game-changing inventions are more likely to reach their potential when backed by original and excellent academic research. In Life Science, a long and complicated journey starts on the lab bench once the first results indicate a novel concept with market potential, and many obstacles will need to be overcome to reach the right market, whether it be with inventive technology or a molecular breakthrough.
One of Botower Capital core missions is the development and transfer of technology to benefit society.
BoTower Capital is accelerating the proof-of-concept stage of projects in the fields of Medtech, Diagnostics and Drug discovery. The company focuses on projects in discovery, pre-seed or seed phase; projects with excellent innovative potential, which will benefit from the project-launching experience and networking skills developed by Micar Innovation & Exact Science Foundation over the last decade. Furthermore, financial support provided by BoTower should significantly increase the appeal and value of a project for further licensees and/ or investors.
BoTower Capital team is benefiting of know-how and experiences gathered in Micar Innovation & Exact Science Foundation within last decade. The team is developing a pool of highly potent biotech projects originating at academia and finding commercial partners for them.
19 July 2018
Botower Capital invest in Melasma Pharmaceuticals spin off company of Micar Innovation with support for incubation space, legal, technology and Business development services.
28 March 2018
Botower Capital invest in Pancreatic Pharmaceuticals spin off company of Micar Innovation with support for incubation space, legal, technology and Business development services.
20 March 2018
Botower Capital invest in Bolka Pharmaceuticals spin off company of Micar Innovation with support for incubation space, legal, technology and Business development services.
20 April 2017
Botower Capital invest in Micar Innovation with support for incubation space, legal, technology and Business development services.
We partner with life science pioneers to change the world for the better.
Botower Capital brings a unique set of companies at top Central & East Europe and Middle East universities and third level research institutions
